News

Valsalakumari R, Feith M, Pettersen S, Åslund AKO, Mørch Ý, Skotland T, Sandvig K, Mælandsmo GM, Iversen TG (2025)
Combinatorial Effects of Free and Nanoencapsulated Forms of Cabazitaxel and RAS-Selective Lethal 3 in Breast Cancer Cells
Pharmaceutics, 17 (5)
DOI 10.3390/pharmaceutics17050657, PubMed 40430947

Heinrich MC, Blay JY, Gelderblom H, George S, Schöffski P, von Mehren M, Zalcberg JR, Jones RL, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Boye K, Goldstein D, Sánchez C, Siontis BL, Cox P, Davis E, Sherman ML, Ruiz-Soto R, Bauer S (2025)
Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE
J Clin Oncol, JCO2402818 (in press)
DOI 10.1200/JCO-24-02818, PubMed 40408605

Samarakoon PS, Fournous G, Hansen LT, Wijesiri A, Zhao S, Alex A R, Nandi TN, Madduri R, Rowe AD, Thomassen G, Hovig E, Razick S (2025)
Benchmarking accelerated next-generation sequencing analysis pipelines
Bioinform Adv, 5 (1), vbaf085
DOI 10.1093/bioadv/vbaf085, PubMed 40395501